Reprogenesis' Series A Round

Reprogenesis raised a round of funding on July 01, 1997.

Reprogenesis is a therapeutic drug development company, focusing on regulatory pathways that control repair and regeneration using proteins or small molecules to modulate these pathways.…

Articles about Reprogenesis' Series A Round: